Sernova (TSX:SVA) stock is cheap, Research Capital says
Following the release of new data on a core offering, Research Capital analyst Andre Uddin remains upbeat about the prospects of Sernova.
Source: cantechletter.com
Page 4 - Cell Pouch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cell Pouch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cell Pouch Today - Breaking & Trending Today
Sernova Presents Compelling New Data on the Cell Pouch
Proof-of-concept data supports the clinical evaluation of the Cell Pouch System as a potential treatment for post-operative hypothyroidism...
Source: globenewswire.com
Sernova Corp. Announces New Preclinical Data for its Novel Cell Therapy Platform, Cell Pouch System, as Potential Treatment for Post-Operative Hypothyroidism at 2023 American Thyroid Association Annual Meeting
Sernova Corp. announced new preclinical data for its novel cell therapy platform, the Cell Pouch System, as a potential treatment for post-operative hypothyroidism at the 2023 American Thyroid...
Source: marketscreener.com
Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September
Issuer: Sernova Corp. / Key word(s): Conference/Miscellaneous14.09.2023 / 22:06 CET/CESTThe issuer is solely responsible for the content of this announcement.LONDON, Ontario; WINDHAM COUNTY, Connecticut – September 14, 2023 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader...
Source: pharmiweb.com
SVA stock has an upside of 369%, Echelon says
Its third quarter results are out the door and Echelon analyst Stefan Quenneville thinks there is a lot of money to be made on Sernova Corp
Source: cantechletter.com